Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update and latest advances in antiretroviral therapy
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir
Dirk Jochmans, Liu C, Kim Donckers, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 127
Global, regional, and national HIV/AIDS disease burden levels and trends in 1990–2019: A systematic analysis for the global burden of disease 2019 study
Xuebin Tian, Jingjing Chen, Xi Wang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 54
Point‐of‐care nucleic acid testing – a step forward in controlling the HIV epidemic: A review
Şükran ERTEKİN PINAR, Mark Manak, Shanmugam Saravanan, et al.
HIV Medicine (2025)
Open Access | Times Cited: 1
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Luis Menéndez‐Arias
Viruses (2022) Vol. 14, Iss. 4, pp. 841-841
Open Access | Times Cited: 42
The substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitorin vitroand confer resistance to nirmatrelvir
Dirk Jochmans, Liu C, Kim Donckers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers
Dominika Žigrayová, Veronika Mikušová, Peter Mikuš
Viruses (2023) Vol. 15, Iss. 3, pp. 647-647
Open Access | Times Cited: 22
Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges
Shaoqing Du, Xueping Hu, Luis Menéndez‐Arias, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101053-101053
Closed Access | Times Cited: 14
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication
Belgin Sever, Masami Otsuka, Mikako Fujita, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3659-3659
Open Access | Times Cited: 11
In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance
Yuao Zhu, Irina Yurgelonis, Stephen Noell, et al.
Science Advances (2024) Vol. 10, Iss. 30
Open Access | Times Cited: 11
In Situ Forming, Enzyme-Responsive Peptoid-Peptide Hydrogels: An Advanced Long-Acting Injectable Drug Delivery System
Sophie Coulter, Sreekanth Pentlavalli, Yuming An, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 31, pp. 21401-21416
Open Access | Times Cited: 10
Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment
Rana Abdelnabi, Dirk Jochmans, Kim Donckers, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Natural products as potential lead compounds to develop new antiviral drugs over the past decade
Jing-Han Zhao, Yuewei Wang, Jin Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115726-115726
Closed Access | Times Cited: 20
Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review
Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu
Viruses (2023) Vol. 15, Iss. 8, pp. 1732-1732
Open Access | Times Cited: 20
HIV Tissue Reservoirs: Current Advances in Research
Kangpeng Li, Bo Liu, Rui Ma, et al.
AIDS Patient Care and STDs (2023) Vol. 37, Iss. 6, pp. 284-296
Closed Access | Times Cited: 19
A Review on FDA Approved Anti-HIV-1 Drugs, Anti-Gag Compounds and Potential Strategies for HIV-1 Eradication
Belgin Sever, Masami Otsuka, Mikako Fujita, et al.
(2024)
Open Access | Times Cited: 5
Structure-based discovery of novel piperidine-biphenyl-DAPY derivatives as non-nucleoside reverse transcriptase inhibitors featuring improved potency, safety, and selectivity: From piperazine-biphenyl-DAPYs to piperidine-biphenyl-DAPYs
Wenjuan Huang, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116668-116668
Closed Access | Times Cited: 5
Clinical events associated with poor CD4+ T-cell recovery in people living with HIV following ART: a systematic review and meta-analysis
Tangwei Mou, Kai-Cheng Gao, Xiyao Chen, et al.
Journal of Infection (2025) Vol. 90, Iss. 2, pp. 106414-106414
Open Access
Next-Generation Sequencing Methods to Determine the Accuracy of Retroviral Reverse Transcriptases: Advantages and Limitations
Javier Martínez del Río, Luis Menéndez‐Arias
Viruses (2025) Vol. 17, Iss. 2, pp. 173-173
Open Access
Development and characterization of a double-fluorescent HIV-1 reporter cellular model to tackle the Rev-dependent export pathway
Jakub Wadas, Haider Ali, A Osiecka, et al.
Microbiology Spectrum (2025)
Open Access
Predicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model
Archana Krishnan, Yerina S. Ranjit, Xin Zhou, et al.
Journal of Behavioral Medicine (2025)
Closed Access
Antivirotics based on defective interfering particles: emerging concepts and challenges
S. V. Maryanchik, S. E. Borovikova, Anna O. Ivanova, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review
Yusuf M. Idres, Adi Idris, Wenqing Gao
Drug Delivery and Translational Research (2025)
Open Access
Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain
Jordi Blanch, Estebán Martínez, Álvaro Mena, et al.
HIV Medicine (2025)
Closed Access
Prevalence and risk factors of tuberculosis among people living with HIV/AIDS in China: a systematic review and meta-analysis
Congcong Qi, Liran Xu, Chang-Jia Zhao, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies
Amina Džidić-Krivić, Emina Karahmet Sher, Jasna Kusturica, et al.
Chemico-Biological Interactions (2023) Vol. 388, pp. 110838-110838
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top